Researchers linked higher frequency of intravitreal anti-VEGF injections with a greater risk for mild cognitive impairment in patients with age-related macular degeneration.
“There have been no formal studies assessing the cognitive impact of these repeated injections in a potentially cognitively-vulnerable age group,” Subhransu K. Ray, MD, PhD, of Bay Area Retina Associates, said in his presentation at the virtual American Society of Retina Specialists meeting. “Although we do know the vitreous communicates directly to the CNS in various pathological states, we know very
Uncategorized